Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the Sixth Board of Directors
Securities code: 002550 Securities abbreviation: Qianhong Pharmaceutical Announcement number: 2026-021
Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 14th Meeting of the 6th Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
1. Convening of board of directors meetings
The notice of the 14th meeting of the sixth board of directors of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or the "Company") was issued by email on July 27, 2026. The meeting was held on August 6, 2026 in the company's conference room by on-site and communication voting. 9 directors should be present at the meeting, and 9 directors were actually present. Among them, Mr. Ning Ao, Mr. Ren Shengxiang, and Ms. Gao Yuyu attended by communication voting. The meeting was convened and chaired by Chairman Wang Yaofang, and the company's senior managers attended the meeting. The notice and convening of this meeting, as well as the number of directors attending and voting, complied with the relevant provisions of the Company Law and other laws and regulations and the Company's Articles of Association.
2. Review status of board of directors meeting
The resolutions reached at this board meeting are as follows:
(1) Reviewed and approved the “Proposal on the Full Text and Summary of the Company’s 2026 Semi-annual Report”
Voting results: 9 votes in favor, 0 votes against, 0 abstentions, and the motion was passed.
"Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. 2026 Semi-Annual Report" and "Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. 2026 Semi-Annual Report Summary" can be found in the information disclosure media: www.cninfo.com.cn. "Summary of the 2026 Semi-Annual Report of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd." was also published in the "Securities Times" and "Shanghai Securities News" on August 8, 2026.
This proposal has been reviewed and approved at the eighth meeting of the Audit Committee of the sixth session of the Board of Directors of the company.
(2) Reviewed and approved the "Proposal on Amending the Company's 2025 Employee Stock Ownership Plan (Draft)" and its Summary
Directors Mr. Zhou Xiang and Mr. Jiang Chizhou abstained from voting as participants in the employee stock ownership plan. The voting results were: 7 votes in favor, 0 abstentions, and 0 votes against, and the motion was passed.
For details of the "2025 Employee Stock Ownership Plan (Draft) (Revised) of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd." and its summary, please see the information disclosure media: Juchao Information Network www.cninfo.com.cn and the "Securities Times" and "Shanghai Securities News" on August 8, 2026.
This proposal has been reviewed and approved at the sixth meeting of the Remuneration and Appraisal Committee of the sixth board of directors of the company.
(3) The "Proposal on Amending the Company's 2025 Employee Stock Ownership Plan Management Measures" was reviewed and approved. Directors Mr. Zhou Xiang and Mr. Jiang Chizhou abstained from voting as participants in the employee stock ownership plan. The voting results were: 7 votes in favor, 0 abstentions, and 0 votes against, and the motion was passed.
The full text of "Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. 2025 Employee Stock Ownership Plan Management Measures (Revised Draft)" can be found in the information disclosure media: Juchao Information Network www.cninfo.com.cn and the "Securities Times" and "Shanghai Securities News" on August 8, 2026.
This proposal has been reviewed and approved at the sixth meeting of the Remuneration and Appraisal Committee of the sixth board of directors of the company.
3. Documents for reference
Resolution of the 14th meeting of the company’s sixth board of directors;
Resolution of the eighth meeting of the Audit Committee of the sixth session of the Board of Directors of the company;
Resolution of the sixth meeting of the Remuneration and Appraisal Committee of the sixth board of directors of the company;
Announcement is hereby made.
Board of Directors of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
August 8, 2026